share_log

HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $26 Price Target

HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $26 Price Target

HC Wainwright & Co.重申買入MediWound,維持26美元的目標價
Benzinga ·  2023/11/22 06:35

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MediWound (NASDAQ:MDWD) with a Buy and maintains $26 price target.

HC Wainwright & Co. 分析師Swayampakula Ramakanth重申了MediWound(納斯達克股票代碼:MDWD)的買入並維持26美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論